Details for 2010824148

Up to date per 13.05.2026

Actions

Title / Product Name

Kombination enthaltend ein MEK Inhibitor und ein B-raf Inhibitor

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2010824148

EP Publication Number

2488033

E-Number

1141699

Language

PCT Number

US10052808

Publication Date

22.08.2012 A

12.06.2019 B1

Registration Date

12.06.2019

AT Publication Date

15.06.2019

Application Date

15.10.2010

Registration Number

Priorities

16.10.2009

252213 P

IPC

A61K 31/506 20060101AFI20181031BHEP

Maximum Duration of Protection

15.10.2030

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

DUMBLE, Melissac/o GlaxoSmithKline Global Patents Dept. 1250 South Collegeville Road P. O. Box 5089 Collegeville, Pennsylvania 19426US

KUMAR, Rakeshc/o GlaxoSmithKline Global Patents Dept. 1250 South Collegeville Road P.O. Box 5089 Collegeville, Pennsylvania 19426US

LAQUERRE, Sylviec/o GlaxoSmithKline Global Patents Dept. 1250 South Collegeville Road P. O. Box 5089 Collegeville, Pennsylvania 19426US

LEBOWITZ, Peterc/o GlaxoSmithKline Global Patents Dept. 1250 South Collegeville Road P. O. Box 5089 Collegeville, Pennsylvania 19426US

Information about Fees